Delivery Order SPE2DB22D2206-SPE2DB24FGD88
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,337.48 firm-fixed-price contract is for the supply of Dupixent 300 mg/2 ml pens, with a performance period through May 14, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $13,270.97 order is for the supply of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product, with a performance period through March 11, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product. The $4,376.03 firm fixed price delivery order has an ultimate completion date of March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,219.13 firm-fixed-price contract is for the delivery of Dupixent 300 mg/2 ml pens and has an ultimate completion date of December 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $18,934.42 award is for the supply of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 held by Amerisourcebergen Drug Corp to provide a comprehensive range of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $7,452.32 order is for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen, with an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company to provide a wide...
- This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution and services company, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product, with a ceiling value of $9,788.80 and a performance period through March 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,709.46, is for the supply of Dupixent 300 mg/2 ml pens, a medication used to treat certain medical conditions. The award is not set-aside and has an ultimate completion date of May 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,261.75 firm fixed-price delivery order contract is for the supply of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product. The contract has an ultimate completion date of November 24, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,340.55 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pens, a specialty medication. The contract has a completion date of January 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGD88Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $8,311.53 contract is for the delivery of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product, with a performance period through March 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order does not have a set-aside designation. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 3/19/24 |